Literature DB >> 8042442

Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities.

A Friedman1.   

Abstract

Of 261 patients with clinically diagnosed Parkinson's disease (PD), whose age at the onset was 58.2 +/- 11.3, 46 patients with the onset age above 70 (the mean for the whole group + 1SD) were compared to 44 patients with onset age below 47 (the mean for the whole group - 1 SD). Old-onset PD patient were more susceptible to develop psychotic complications of levodopa treatment. More often had they tremor both as presenting and dominant symptom of their disease. Among young-onset PD bradykinesia was more often the dominant clinical feature, and susceptibility to levodopa induced dyskinesia was higher. In 9 cases of young-onset PD (20.5% of this group) paraesthesia was a presenting symptom, compared to only 1 patient (2%) in the group of old-onset PD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042442     DOI: 10.1111/j.1600-0404.1994.tb01676.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

Review 1.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

2.  Psychiatric symptoms screening in the early stages of Parkinson's disease.

Authors:  Paulo Bugalho; Joaquim Alves da Silva; Inês Cargaleiro; Madalena Serra; Bernardo Neto
Journal:  J Neurol       Date:  2011-06-21       Impact factor: 4.849

3.  Late aging-associated increases in L-DOPA-induced dyskinesia are accompanied by heightened neuroinflammation in the hemi-parkinsonian rat.

Authors:  Kathryn Lanza; Amy E Perkins; Terrence Deak; Christopher Bishop
Journal:  Neurobiol Aging       Date:  2019-05-31       Impact factor: 4.673

4.  Gender and iron genes may modify associations between brain iron and memory in healthy aging.

Authors:  George Bartzokis; Po H Lu; Kathleen Tingus; Douglas G Peters; Chetan P Amar; Todd A Tishler; J Paul Finn; Pablo Villablanca; Lori L Altshuler; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  Neuropsychopharmacology       Date:  2011-03-09       Impact factor: 7.853

Review 5.  Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials.

Authors:  K Biglan; R G Holloway
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 6.  Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.

Authors:  Raja Mehanna; Katarzyna Smilowska; Jori Fleisher; Bart Post; Taku Hatano; Maria Elisa Pimentel Piemonte; Kishore Raj Kumar; Victor McConvey; Baorong Zhang; Eng-King Tan; Rodolfo Savica
Journal:  Mov Disord Clin Pract       Date:  2022-09-10

Review 7.  Therapy of Parkinson's Disease Subtypes.

Authors:  Connie Marras; K Ray Chaudhuri; Nataliya Titova; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

8.  Altered regulation of CD200 receptor in monocyte-derived macrophages from individuals with Parkinson's disease.

Authors:  Xiao-Guang Luo; Ji-Juan Zhang; Chao-Dong Zhang; Rong Liu; Lan Zheng; Xi-Jin Wang; Sheng-Di Chen; Jian-Qing Ding
Journal:  Neurochem Res       Date:  2010-04       Impact factor: 3.996

Review 9.  Surgical Management of Parkinson's Disease in the Elderly.

Authors:  Paula Azevedo; Camila C Aquino; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2021-02-27

10.  Early-Onset Parkinsonism and Early-Onset Parkinson's Disease: A Population-Based Study (2010-2015).

Authors:  Emanuele Camerucci; Cole D Stang; Mania Hajeb; Pierpaolo Turcano; Aidan F Mullan; Peter Martin; Owen A Ross; James H Bower; Michelle M Mielke; Rodolfo Savica
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.